Cargando…

Correction: Stereotactic ablative radiotherapy or best supportive care in patients with localized pancreatic cancer not receiving chemotherapy and surgery (PANCOSAR): a nationwide multicenter randomized controlled trial according to a TwiCs design

Detalles Bibliográficos
Autores principales: Doppenberg, D., Besselink, M. G., van Eijck, C. H. J., Intven, M. P. W., Groot Koerkamp, B., Kazemier, G., van Laarhoven, H. W. M., Meijerink, M., Molenaar, I. Q., Nuyttens, J. J. M. E., van Os, R., van Santvoort, H. C., van Tienhoven, G., Verkooijen, H. M., Versteijne, E., Wilmink, J. W., Lagerwaard, F. J., Bruynzeel, A. M. E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9854019/
https://www.ncbi.nlm.nih.gov/pubmed/36670370
http://dx.doi.org/10.1186/s12885-023-10521-1
_version_ 1784873026074968064
author Doppenberg, D.
Besselink, M. G.
van Eijck, C. H. J.
Intven, M. P. W.
Groot Koerkamp, B.
Kazemier, G.
van Laarhoven, H. W. M.
Meijerink, M.
Molenaar, I. Q.
Nuyttens, J. J. M. E.
van Os, R.
van Santvoort, H. C.
van Tienhoven, G.
Verkooijen, H. M.
Versteijne, E.
Wilmink, J. W.
Lagerwaard, F. J.
Bruynzeel, A. M. E.
author_facet Doppenberg, D.
Besselink, M. G.
van Eijck, C. H. J.
Intven, M. P. W.
Groot Koerkamp, B.
Kazemier, G.
van Laarhoven, H. W. M.
Meijerink, M.
Molenaar, I. Q.
Nuyttens, J. J. M. E.
van Os, R.
van Santvoort, H. C.
van Tienhoven, G.
Verkooijen, H. M.
Versteijne, E.
Wilmink, J. W.
Lagerwaard, F. J.
Bruynzeel, A. M. E.
author_sort Doppenberg, D.
collection PubMed
description
format Online
Article
Text
id pubmed-9854019
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-98540192023-01-21 Correction: Stereotactic ablative radiotherapy or best supportive care in patients with localized pancreatic cancer not receiving chemotherapy and surgery (PANCOSAR): a nationwide multicenter randomized controlled trial according to a TwiCs design Doppenberg, D. Besselink, M. G. van Eijck, C. H. J. Intven, M. P. W. Groot Koerkamp, B. Kazemier, G. van Laarhoven, H. W. M. Meijerink, M. Molenaar, I. Q. Nuyttens, J. J. M. E. van Os, R. van Santvoort, H. C. van Tienhoven, G. Verkooijen, H. M. Versteijne, E. Wilmink, J. W. Lagerwaard, F. J. Bruynzeel, A. M. E. BMC Cancer Correction BioMed Central 2023-01-20 /pmc/articles/PMC9854019/ /pubmed/36670370 http://dx.doi.org/10.1186/s12885-023-10521-1 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Correction
Doppenberg, D.
Besselink, M. G.
van Eijck, C. H. J.
Intven, M. P. W.
Groot Koerkamp, B.
Kazemier, G.
van Laarhoven, H. W. M.
Meijerink, M.
Molenaar, I. Q.
Nuyttens, J. J. M. E.
van Os, R.
van Santvoort, H. C.
van Tienhoven, G.
Verkooijen, H. M.
Versteijne, E.
Wilmink, J. W.
Lagerwaard, F. J.
Bruynzeel, A. M. E.
Correction: Stereotactic ablative radiotherapy or best supportive care in patients with localized pancreatic cancer not receiving chemotherapy and surgery (PANCOSAR): a nationwide multicenter randomized controlled trial according to a TwiCs design
title Correction: Stereotactic ablative radiotherapy or best supportive care in patients with localized pancreatic cancer not receiving chemotherapy and surgery (PANCOSAR): a nationwide multicenter randomized controlled trial according to a TwiCs design
title_full Correction: Stereotactic ablative radiotherapy or best supportive care in patients with localized pancreatic cancer not receiving chemotherapy and surgery (PANCOSAR): a nationwide multicenter randomized controlled trial according to a TwiCs design
title_fullStr Correction: Stereotactic ablative radiotherapy or best supportive care in patients with localized pancreatic cancer not receiving chemotherapy and surgery (PANCOSAR): a nationwide multicenter randomized controlled trial according to a TwiCs design
title_full_unstemmed Correction: Stereotactic ablative radiotherapy or best supportive care in patients with localized pancreatic cancer not receiving chemotherapy and surgery (PANCOSAR): a nationwide multicenter randomized controlled trial according to a TwiCs design
title_short Correction: Stereotactic ablative radiotherapy or best supportive care in patients with localized pancreatic cancer not receiving chemotherapy and surgery (PANCOSAR): a nationwide multicenter randomized controlled trial according to a TwiCs design
title_sort correction: stereotactic ablative radiotherapy or best supportive care in patients with localized pancreatic cancer not receiving chemotherapy and surgery (pancosar): a nationwide multicenter randomized controlled trial according to a twics design
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9854019/
https://www.ncbi.nlm.nih.gov/pubmed/36670370
http://dx.doi.org/10.1186/s12885-023-10521-1
work_keys_str_mv AT doppenbergd correctionstereotacticablativeradiotherapyorbestsupportivecareinpatientswithlocalizedpancreaticcancernotreceivingchemotherapyandsurgerypancosaranationwidemulticenterrandomizedcontrolledtrialaccordingtoatwicsdesign
AT besselinkmg correctionstereotacticablativeradiotherapyorbestsupportivecareinpatientswithlocalizedpancreaticcancernotreceivingchemotherapyandsurgerypancosaranationwidemulticenterrandomizedcontrolledtrialaccordingtoatwicsdesign
AT vaneijckchj correctionstereotacticablativeradiotherapyorbestsupportivecareinpatientswithlocalizedpancreaticcancernotreceivingchemotherapyandsurgerypancosaranationwidemulticenterrandomizedcontrolledtrialaccordingtoatwicsdesign
AT intvenmpw correctionstereotacticablativeradiotherapyorbestsupportivecareinpatientswithlocalizedpancreaticcancernotreceivingchemotherapyandsurgerypancosaranationwidemulticenterrandomizedcontrolledtrialaccordingtoatwicsdesign
AT grootkoerkampb correctionstereotacticablativeradiotherapyorbestsupportivecareinpatientswithlocalizedpancreaticcancernotreceivingchemotherapyandsurgerypancosaranationwidemulticenterrandomizedcontrolledtrialaccordingtoatwicsdesign
AT kazemierg correctionstereotacticablativeradiotherapyorbestsupportivecareinpatientswithlocalizedpancreaticcancernotreceivingchemotherapyandsurgerypancosaranationwidemulticenterrandomizedcontrolledtrialaccordingtoatwicsdesign
AT vanlaarhovenhwm correctionstereotacticablativeradiotherapyorbestsupportivecareinpatientswithlocalizedpancreaticcancernotreceivingchemotherapyandsurgerypancosaranationwidemulticenterrandomizedcontrolledtrialaccordingtoatwicsdesign
AT meijerinkm correctionstereotacticablativeradiotherapyorbestsupportivecareinpatientswithlocalizedpancreaticcancernotreceivingchemotherapyandsurgerypancosaranationwidemulticenterrandomizedcontrolledtrialaccordingtoatwicsdesign
AT molenaariq correctionstereotacticablativeradiotherapyorbestsupportivecareinpatientswithlocalizedpancreaticcancernotreceivingchemotherapyandsurgerypancosaranationwidemulticenterrandomizedcontrolledtrialaccordingtoatwicsdesign
AT nuyttensjjme correctionstereotacticablativeradiotherapyorbestsupportivecareinpatientswithlocalizedpancreaticcancernotreceivingchemotherapyandsurgerypancosaranationwidemulticenterrandomizedcontrolledtrialaccordingtoatwicsdesign
AT vanosr correctionstereotacticablativeradiotherapyorbestsupportivecareinpatientswithlocalizedpancreaticcancernotreceivingchemotherapyandsurgerypancosaranationwidemulticenterrandomizedcontrolledtrialaccordingtoatwicsdesign
AT vansantvoorthc correctionstereotacticablativeradiotherapyorbestsupportivecareinpatientswithlocalizedpancreaticcancernotreceivingchemotherapyandsurgerypancosaranationwidemulticenterrandomizedcontrolledtrialaccordingtoatwicsdesign
AT vantienhoveng correctionstereotacticablativeradiotherapyorbestsupportivecareinpatientswithlocalizedpancreaticcancernotreceivingchemotherapyandsurgerypancosaranationwidemulticenterrandomizedcontrolledtrialaccordingtoatwicsdesign
AT verkooijenhm correctionstereotacticablativeradiotherapyorbestsupportivecareinpatientswithlocalizedpancreaticcancernotreceivingchemotherapyandsurgerypancosaranationwidemulticenterrandomizedcontrolledtrialaccordingtoatwicsdesign
AT versteijnee correctionstereotacticablativeradiotherapyorbestsupportivecareinpatientswithlocalizedpancreaticcancernotreceivingchemotherapyandsurgerypancosaranationwidemulticenterrandomizedcontrolledtrialaccordingtoatwicsdesign
AT wilminkjw correctionstereotacticablativeradiotherapyorbestsupportivecareinpatientswithlocalizedpancreaticcancernotreceivingchemotherapyandsurgerypancosaranationwidemulticenterrandomizedcontrolledtrialaccordingtoatwicsdesign
AT lagerwaardfj correctionstereotacticablativeradiotherapyorbestsupportivecareinpatientswithlocalizedpancreaticcancernotreceivingchemotherapyandsurgerypancosaranationwidemulticenterrandomizedcontrolledtrialaccordingtoatwicsdesign
AT bruynzeelame correctionstereotacticablativeradiotherapyorbestsupportivecareinpatientswithlocalizedpancreaticcancernotreceivingchemotherapyandsurgerypancosaranationwidemulticenterrandomizedcontrolledtrialaccordingtoatwicsdesign
AT correctionstereotacticablativeradiotherapyorbestsupportivecareinpatientswithlocalizedpancreaticcancernotreceivingchemotherapyandsurgerypancosaranationwidemulticenterrandomizedcontrolledtrialaccordingtoatwicsdesign